Other news to note
Thursday, January 9, 2014
Biolinerx Ltd., of Jerusalem, signed a collaboration agreement with JHL Biotech, of Hsinchu, Taiwan, to develop and commercialize BL-9020 for Type I diabetes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.